Results 221 to 230 of about 10,751,278 (348)

Predicting viral host codon fitness and path shifting through tree-based learning on codon usage biases and genomic characteristics. [PDF]

Sci Rep
Su S, Ni Z, Lan T, Ping P, Tang J, Yu Z, Hutvagner G, Li J.   +7 more
europepmc   +1 more source

Glossary of Bioinformatics Terms [PDF]

, 2015
National Human Genome Research Institute
core   +1 more source

The Human Genome Project: the next decade [PDF]

, 2002
Gardiner, RM
core   +2 more sources

Genome sequence of the human malaria parasite Plasmodium falciparum

Nature, 2002
M. Gardner, N. Hall, E. Fung, O. White, M. Berriman, R. Hyman, J. Carlton, A. Pain, K. Nelson, S. Bowman, I. Paulsen, K. James, J. Eisen, Kim M Rutherford, S. Salzberg, A. Craig, S. Kyes, Man-Suen Chan, V. Nene, S. Shallom, Bernard B. Suh, J. Peterson, Samuel V. Angiuoli, M. Perțea, Jonathan E. Allen, J. Selengut, D. Haft, M. Mather, A. Vaidya, David M. A. Martin, A. Fairlamb, M. Fraunholz, D. Roos, S. Ralph, G. McFadden, L. M. Cummings, G. Subramanian, C. Mungall, J. Venter, D. Carucci, S. Hoffman, C. Newbold, Ronald W. Davis, C. Fraser, B. Barrell   +44 more
semanticscholar   +1 more source

Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon‐19‐deleted advanced NSCLC mutation

FEBS Open Bio, EarlyView.
Osimertinib reduces angiogenesis and PDL1 expression in in ovo tumors, transforming them into ‘cold tumors’ with lower immune activity. Anatomopathological and transcriptomic analyses highlight its therapeutic impact on tumor biology. This study underscores osimertinib's potential to reshape the tumor microenvironment and provides insights into its ...
David Barthélémy, Arnaud Vigneron, Xavier Rousset, Jérome Guitton, Emmanuel Grolleau, Margaux Raffin, Julie Balandier, Gaëlle Lescuyer, Mathilde Bardou, Florence Geiguer, Sébastien Couraud, Claire Bardel, Jean Viallet, Nazim Benzerdjeb, Léa Payen   +14 more
wiley   +1 more source

REPrise: de novo interspersed repeat detection using inexact seeding. [PDF]

Mob DNA
Takeda A, Nonaka D, Imazu Y, Fukunaga T, Hamada M.   +4 more
europepmc   +1 more source

Global variation in copy number in the human genome

Nature, 2006
R. Redon, S. Ishikawa, Karen R. Fitch, L. Feuk, L. Feuk, G. Perry, T. Andrews, H. Fiegler, M. Shapero, A. Carson, A. Carson, Wenwei Chen, Eun Kyung Cho, Stephanie Dallaire, J. Freeman, J. González, M. Gratacós, Jing Huang, Dimitrios Kalaitzopoulos, Daisuke Komura, J. MacDonald, C. Marshall, C. Marshall, R. Mei, Lyndal Montgomery, Keunihiro Nishimura, Kohji Okamura, Kohji Okamura, F. Shen, M. Somerville, J. Tchinda, A. Valsesia, Cara Woodwark, Fengtang Yang, Junjun Zhang, T. Zerjal, Jane Zhang, L. Armengol, D. Conrad, X. Estivill, X. Estivill, C. Tyler-Smith, N. Carter, H. Aburatani, Charles Lee, Charles Lee, K. W. Jones, S. Scherer, S. Scherer, M. Hurles   +49 more
semanticscholar   +1 more source

Tryptophan‐sensing receptor GPR142 expression levels are directly regulated by proinflammatory cytokines in ghrelin‐producing cells

FEBS Open Bio, EarlyView.
GPR142, a tryptophan‐sensing receptor, stimulates gastrointestinal hormones like ghrelin and is linked to inflammation regulation. Proinflammatory cytokines suppress ghrelin production, while tryptophan levels decrease via IDO1 activation. Our findings reveal that proinflammatory cytokines directly regulate GPR142 expression in ghrelin‐producing cells,
Yoko Ueda, Hiroshi Iwakura, Takuya Ensho, Mika Bando‐Shimizu, Asako Doi, Norihiko Matsutani, Shuhei Morita, Hidefumi Inaba, Hiroyuki Ariyasu, Naoki Fukuda, Keiji Hayata, Toshiyasu Ojima, Masahiro Nishi, Taka‐aki Matsuoka, Hiroki Yamaue, Takashi Akamizu   +15 more
wiley   +1 more source

Fully resolved genome assembly of a <i>Macrococcus bovicus</i> isolated from a human skin infection. [PDF]

Microbiol Resour Announc
Fernandez JE, Collaud A, Jost G, Perreten V, Liassine N.   +4 more
europepmc   +1 more source

A potential tumor suppressor role of PLK2 in glioblastoma

FEBS Open Bio, EarlyView.
PLK2 was consistently downregulated in GBM tissues. Overexpression of PLK2 in GBM cell lines U87MG and U251 reduced their tumorigenic potential and enhanced cell cycle arrest and apoptosis. Suggesting that PLK2 overexpression could potentially be leveraged as a therapeutic strategy to inhibit tumor progression and enhance apoptosis, providing new ...
Xiangping Xia, Peirui Wang, Hua Xiao, Qishan Ran, Yan Li, Shengtao Yao   +5 more
wiley   +1 more source